COLD-FX Lawsuit Media Statement

TORONTO, April 5, 2016 /CNW/ - COLD-FX is a clinically proven formula.  It helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.i  We categorically deny allegations being made against COLD-FX in the proposed class action.  We look forward to defending the brand in court this week. 

COLD-FX is a proud Canadian Natural Health Product (NHP) supported by over 10 years of research, including randomized controlled clinical trials published in peer-reviewed medical journals, and we value our consumers' ongoing support.  We encourage you to review our website which contains helpful information on COLD-FX, including Myth Busters COLD-FX.

COLD-FX is produced by Valeant Canada, a subsidiary of Valeant Pharmaceuticals International, Inc., a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.  More information about COLD-FX can be found at  More information about Valeant Canada can be found at

i "COLD-FX Monograph" Available at: Accessed April 4, 2016


For further information: Rob McEwan, Argyle Communications, 416-968-7311,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890